Cellomics, Inc. Rallies The Largest Gathering Of High Content Screening And Analysis Expertise At Annual User Group Meeting
10/19/2005 5:12:24 PM
PITTSBURGH--(BUSINESS WIRE)--Jan. 18, 2005--As the leader and founder of HCS, Cellomics, Inc. is pleased to be the executive sponsor of the Cambridge Healthtech Institute (CHI) annual High Content Analysis conference to be held in San Francisco January 25-28, 2005 where they will hold their annual User Group meeting. With continued growth in the use of high content screening (HCS) and analysis for cell biology, CHI is expecting a remarkable turn out at this year's conference.
comments powered by